Core Viewpoint - The company Jieqiang Equipment (300875.SZ) faces significant operational challenges and regulatory scrutiny despite its stock price performing well in the market. The company has been ordered to rectify internal control deficiencies and has experienced ongoing financial losses since its IPO in 2020 [2][3][4]. Regulatory Issues - Jieqiang Equipment received an administrative regulatory decision from the Tianjin Securities Regulatory Bureau due to internal control deficiencies, leading to warnings issued to four senior executives, including the chairman and general manager [2][5][6]. - The company has been found to have significant issues in financial and contract management, including improper use of employee personal bank accounts for transactions and signing of fictitious contracts [5][6]. Financial Performance - The company reported a loss of 0.23 billion yuan in the first three quarters of 2025, with cumulative losses of 3.86 billion yuan since 2022 [3][14]. - Since its IPO, Jieqiang Equipment has accumulated a net profit loss of 2.56 billion yuan, with a notable decline in profitability since 2021 [4][14]. Stock Market Performance - Despite the financial struggles, Jieqiang Equipment's stock has seen a significant increase, rising over 70% since the beginning of 2025, with a remarkable 2.2 times increase in stock price from April 9 to August 8 [4][15]. Company Background - Established in November 2005, Jieqiang Equipment focuses on the research, production, and sales of nuclear and biochemical safety equipment, aiming to provide integrated solutions in public safety and environmental protection [11].

捷强装备(300875.SZ)跌8.88%，报53.08元，总市值52.99亿元。捷强装备公告，2025年上半年营业收入1.07亿元，同比增长1.44%。归属于上市公司股东的净 亏损868.66万元，上年同期净利润124.34万元。市场竞争激烈，公司核辐射监测产品毛利下降，导致净利润减少；因液压动力系统产品订单减少，导致收入 规模减少，同时由于产品价格调整，毛利有较大幅度下降。(格隆汇) ...

格隆汇8月26日｜捷强装备公告，2025年上半年营业收入1.07亿元，同比增长1.44%。归属于上市公司股 东的净亏损868.66万元，上年同期净利润124.34万元。市场竞争激烈，公司核辐射监测产品毛利下降， 导致净利润减少；因液压动力系统产品订单减少，导致收入规模减少，同时由于产品价格调整，毛利有 较大幅度下降。 ...